Innovative research

The innovative CRO and drug discovery company specialized in neurodegenerative diseases

NEWS

Preclinical services

Neuro-Sys has developed specific preclinical in vitro models of CNS diseases to achieve high-quality efficacy pharmacology as well as mode of action studies, a unique cost-effective strategy to accurately determine the pharmacological profiling of leads compounds and explore their underlying mechanism of action. We provide studies to determine the neuroprotection activity of leads compounds but also of dietary supplements and medical nutrition.
We are dedicated to provide high-level technical expertise and preclinical CRO services in a collaborative relationship with our clients, mainly focusing on :

› Alzheimer’s disease (AD)
› Parkinson’s disease (PD)
› Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease)
› Multiple Sclerosis (MS)
› Peripheral Neuropathies

A different approach, Our pharmacology platforms have been designed to accept different entity sources such as :
Plant(s)
Simplified Plant Extract
(SPE)
Compounds
(natural or chemical source)

Drug discovery

Neuro-Sys is developing a pipeline of innovative compounds focused on treatments for neurodegenerative diseases, orphan diseases and auto-immune diseases, both internally and through collaborations. We identify our lead compound using our innovative and cutting-edge technology platform, including our proprietary manufacturing process.